Skip to content

Betaxolol

Published: July 26, 2026Updated: July 26, 2026

Betaxolol is a cardioselective beta-1 blocker used primarily to treat hypertension and certain eye conditions like glaucoma. Unlike non-selective beta-blockers, it targets primarily the heart with minimal effect on the lungs and peripheral blood vessels.

Quick summary

A heart-selective beta-blocker for managing high blood pressure and eye pressure.

Medically reviewed by WellAlly Editorial TeamLast reviewed July 26, 2026Editorial policy

Key facts at a glance

ATC
C07AB05
RxNorm
1520
Generic
Betaxolol
Class
atc-c07
Brands
Betoptic S
Availability
rx
Lactation
unknown
Routes
ophthalmic, oral
Forms
suspension, solution, tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Consult local poison control center for specific information
Chronic overdose: Varies by patient
Immediate actions
Call poison control center: 1-800-222-1222
Poison Control: 1-800-222-1222

Special Populations

8 groups
✗

pregnancy

first trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks

Monitor

regular fetal monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

second trimester
unsafe
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

discontinue if pregnancy detected or avoid use unless essential

Monitor

regular fetal growth monitoring

Use of this medication in this population requires careful consideration of risks and benefits.

✗

pregnancy

third trimester
unsafe
FDA Category
C
Dose Adjustment

avoid - discontinue before delivery

Key Recommendations

discontinue at least 48-72 hours before delivery to reduce neonatal effects

Monitor

neonatal monitoring for bradycardia and hypoglycemia

Use of this medication in this population requires careful consideration of risks and benefits.

✗

lactation

breastfeeding
unsafe
FDA Category
C
Dose Adjustment

avoid during breastfeeding

Key Recommendations

do not breastfeed while taking betaxolol - drug excreted in breast milk

Monitor

monitor infant for signs of beta-blockade

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

geriatric

elderly
caution
FDA Category
N
Dose Adjustment

reduce dose - start at lowest effective dose

Key Recommendations

use with caution due to increased sensitivity and reduced clearance

Monitor

monitor blood pressure and heart rate regularly

Use with caution and monitor for adverse effects.

✗

pediatric_age

children under 12
unsafe
FDA Category
C
Dose Adjustment

not recommended for pediatric use

Key Recommendations

betaxolol is not approved for use in children - insufficient safety data

Monitor

not applicable

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

renal_impairment

severe renal impairment
caution
FDA Category
N
Dose Adjustment

reduce dose by 50%

Key Recommendations

use lower dose and monitor renal function closely

Monitor

monitor renal function and drug levels if available

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

severe hepatic impairment
caution
FDA Category
N
Dose Adjustment

reduce dose by 50%

Key Recommendations

use with caution - betaxolol undergoes hepatic metabolism

Monitor

monitor liver function and clinical response

Use with caution and monitor for adverse effects.

Statistics and clinical data

drug_classWHO
2023

Drug class

Value:Selective beta-1 adrenergic antagonist (beta-blocker)

Pharmacological classification of Betaxolol

usageFDA
2023

Common uses

Value:Treatment of glaucoma and ocular hypertension

Primary therapeutic indication for Betoptic S

prescribingFDA
2023

FDA approval year

Value:1989

Betoptic S ophthalmic formulation approval

mechanismFDA
2023

Mechanism of action

Value:Reduces intraocular pressure by decreasing aqueous humor production

Primary pharmacological action

Betaxolol is primarily prescribed for hypertension (high blood pressure) and glaucoma or ocular hypertension (elevated pressure inside the eye). It may also be used in some cases for angina (chest pain) and cardiac arrhythmias.

Betaxolol works by selectively blocking beta-1 adrenergic receptors in the heart, reducing heart rate and the force of heart contractions. This decreases cardiac output and blood pressure. As an eye drop, it reduces fluid production within the eye, lowering intraocular pressure.

May cause bradycardia, fatigue, or dizziness. Should not be stopped abruptly as this can worsen heart conditions. Caution is advised in patients with asthma or COPD, as even selective beta-blockers may affect breathing in high doses. Inform your doctor of all medications before use, as drug interactions are possible.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed July 26, 2026. · Read our editorial policy